StockTwits, founded in 2008 by Howard Lindzon and Soren Macbeth, is a leading social media platform designed specifically for investors and traders to share real-time market insights, ideas, and strategies. Headquartered in New York City, the company pioneered the use of "cashtags" (e.g., $AAPL) to organize financial discussions, initially integrating with Twitter before evolving into a standalone network.
The carmaker, however, reported Q4 adjusted earnings per share of $0.13, below the $0.39 reported in the corresponding quarter of 2024, and lower than an analyst estimate of $0.19.
The selloff in SCHW stock came after technology platform Altruist on Tuesday launched a new AI-powered tax planning tool within its Hazel platform causing a stir among investors over the firm's advisory practice.
Electrek reported on Tuesday, citing a customer quote, that the EV maker is quoting $290,000 for the 500-mile Long Range version of the vehicle, before destination fees and taxes.
According to a report from CNBC that cited two people familiar with the matter, Alphabet on Tuesday went to the European market to raise about $11 billion in sterling and Swiss francs.
According to a report from Reuters, Hammack said on Tuesday that the Federal Reserve is not in a hurry to alter interest rates this year as it sees a “cautiously optimistic” outlook for economic activity in the country.
As per the data from Bloomberg Intelligence, equity turnover averaged a record $1.03 trillion in January, a roughly 50% increase from the same period in 2025.
The company announced positive preclinical results from a study evaluating GDNF as a potential treatment for obesity and metabolic-associated steatotic liver disease.
During an interview with CNBC, Mansour stated that halftime performer Bad Bunny’s opening song crossed the $100 million mark in terms of trading volumes on the platform.
The venture will be structured with Americas Gold and Silver holding a 51% stake and US Antimony holding a 49% stake, with the latter acting as the managing member.
The company announced a memorandum of understanding with Simera Sense to develop next-generation hyperspectral imaging technology for Earth observation satellites.
Nektar announced positive results from the 36-week blinded maintenance period of the 52-week REZOLVE-AD study of its experimental drug, rezpegaldesleukin.
Medicare will reimburse the company’s NeXT Personal molecular residual disease (MRD) test when used to monitor patients with early to mid-stage non-small cell lung cancer (NSCLC).
According to a Business Insider report, Spitznagel believes equities are nearing a blow-off phase and he expects enthusiasm to intensify in the coming months before markets reverse sharply.
